7hon MSN
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with ...
At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Novo Nordisk CEO Mike ...
Novo Nordisk's oral Wegovy pill has exceeded 3 million prescriptions in the U.S. within five months, expanding the obesity ...
A mom in America who couldn't afford GLP-1 injections has started the new "cheaper" Wegovy pill that's currently awaiting ...
Novo Nordisk announced Wegovy (semaglutide) tablets 25 mg have surpassed three million prescriptions in just over five months, establishing Wegovy pill as one of the strongest US pharmaceutical ...
Eli Lilly LLY stock continues to hit new all-time highs as the drugmaker keeps delivering a steady stream of positive ...
Clever Culture Systems (ASX:CC5) has won an order from CSL Behring, which will lease the company’s innovative Automated Plate ...
These world class ASX ETFs provide investors with access to some of the biggest and best stocks from across the ...
Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary DehydraTECH KELOWNA, BC / ACCESS Newswire / June 9, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexari ...
The global geopolitical landscape has plunged into a deep state of uncertainty once again following a direct exchange of ...
AMRX is expanding into GLP-1 manufacturing and biosimilars, using partnerships and acquisitions to strengthen its higher-value product strategy.
Let's "separate the science from the snake oil," says delegate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results